Women’s health company Minerva Surgical (Nasdaq:UTRS) announced that it appointed Kaile Zagger as its new chief commercial officer. Zagger’s role includes helping to guide the strategic growth of the company as it advances in the women’s healthcare space. “We are excited to have Kaile as our new Chief Commercial Officer for her proven track record […]
Minerva Surgical Inc.
Minerva Surgical closes $30M financing, has new controlling stockholder
Minerva Surgical (Nasdaq:UTRS) announced today that it closed a private placement worth approximately $30 million. Santa Clara, California-based Minerva sold more than 146.6 million shares of its common stock at $0.0246 per share. Accelmed Partners led the private placement with participation by New Enterprise Associates. The financing makes Accelmed the controlling stockholder of Minerva Surgical. […]
Minerva Surgical CEO retires, former Activ Surgical head Todd Usen named as replacement
Minerva Surgical (Nasdaq:UTRS) announced that it appointed Todd Usen to replace retiring President and CEO David Clapper. Clapper served as president and CEO of the abnormal uterine bleeding (AUB) treatment developer since 2011. Minerva selected Former Activ Surgical CEO Todd Usen to take over those roles and become a member of the board, effective Jan. […]
SCOTUS preserves assignor estoppel in Minerva Surgical v. Hologic patent case
The U.S. Supreme Court, in its Minerva Surgical v. Hologic ruling today preserved the legal doctrine of assignor estoppel — that inventors who sell patent rights can’t then claim they’re invalid. However, Justice Elena Kagan, in her opinion for the majority, did say that the doctrine has limits. Get the full story on our sister […]
Minerva Surgical closes on Boston Sci intrauterine health franchise buy
Minerva Surgical today said it closed the acquisition of Boston Scientific’s intrauterine health franchise. The financial details of the deal were not disclosed. The new combination of devices includes the Minerva Endometrial Ablation System and the Genesys HTA Endometrial Ablation System for visualization in the uterine cavity during treatment. The deal also includes the Symphion […]
Minerva Surgical raises $10m
Minerva Surgical filed an SEC Form D to confirm the sale of $10 million in an offering of debt, options, warrants and other securities. The Redwood City, Calif.–based company’s new notice completed the first sale of the $10.5 million offering on Nov. 22 and expects to sell the remaining $500,000 before the offering has lasted […]
Minerva Surgical claims win against Hologic
Minerva Surgical today claimed a win in its patent infringement war with Hologic (NSDQ:HOLX) over endometrial ablation technology, after a federal appeals court upheld a ruling that invalidates one of the Hologic patents in question. The convoluted battle involves the NovaSure device Hologic acquired with the 2007 buyout of Cytyc (which had acquired NovaSure developer Novacept […]
Judge denies Minerva Surgical’s bid for new trial in $5m loss to Hologic
UPDATED May 6, 2019, with comment from Minerva. A Delaware federal judge this week denied Minerva Surgical‘s bid for a new trial in its $5 million patent infringement loss to Hologic (NSDQ:HOLX), despite an appeals court ruling last month that invalidated one of the patents at issue. Hologic’s NovaSure ablation device, acquired with the 2007 buyout […]
Appeals court hands Hologic a loss in patent spat with Minerva Surgical
The U.S. Court of Appeals for the Federal Circuit today ruled against Hologic (NSDQ:HOLX) in a patent spat with Minerva Surgical, upholding a ruling from the U.S. Patent Trial and Appeal Board that claims on a patent Hologic owns, related to detecting perforations in body cavities during ablation, are unpatentable as obvious. In the case, Minerva […]
Minerva Surgical raises $9m for endometrial ablation tech
Minerva Surgical has raised $9.2 million from 17 investors as part of a $10 million offering, according to a document filed with the SEC this week. The Redwood City, CA.-based company makes the Minerva endometrial ablation system – a treatment designed to help women manage heavy menstrual bleeding. Heaving bleeding, which occurs in women between […]
Hologic wins $5m from Minerva Surgical in patent infringement spat
A federal court jury last week awarded Hologic (NSDQ:HOLX) nearly $5 million in damages in a patent infringement lawsuit brought over their respective endometriosis devices. Hologic’s NovaSure ablation device, acquired with the 2007 buyout of Cytyc (which acquired NovaSure developer Novacept in 2004), competes with Minerva’s Aurora device. Hologic sued Minerva in November 2015 in the […]